|
1
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends-an update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lassi K and Dawson NA: Emerging therapies
in castrate-resistant prostate cancer. Curr Opin Oncol. 21:260–265.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katsuno Y, Lamouille S and Derynck R:
TGF-β signaling and epithelial-mesenchymal transition in cancer
progression. Curr Opin Oncol. 25:76–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Timmerman LA, Grego-Bessa J, Raya A,
Bertrán E, Pérez-Pomares JM, Díez J, Aranda S, Palomo S, McCormick
F, Izpisúa-Belmonte JC, et al: Notch promotes
epithelial-mesenchymal transition during cardiac development and
oncogenic transformation. Genes Dev. 18:99–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou BP, Deng J, Xia W, Xu J, Li YM,
Gunduz M and Hung MC: Dual regulation of Snail by
GSK-3beta-mediated phosphorylation in control of
epithelial-mesenchymal transition. Nat Cell Biol. 6:931–940. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Impei S, Gismondi A, Canuti L and Canini
A: Metabolic and biological profile of autochthonous Vitis
vinifera L. ecotypes. Food Funct. 6:1526–1538. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kinghorn AD, Su BN, Jang DS, Chang LC, Lee
D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ, et al:
Natural inhibitors of carcinogenesis. Planta Med. 70:691–705. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh B, Bhat TK and Singh B: Potential
therapeutic applications of some antinutritional plant secondary
metabolites. J Agric Food Chem. 51:5579–5597. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Masuda T, Miura Y, Inai M and Masuda A:
Enhancing effect of a cysteinyl thiol on the antioxidant activity
of flavonoids and identification of the antioxidative thiol adducts
of myricetin. Biosci Biotechnol Biochem. 77:1753–1758. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kuhlmann CR, Schaefer CA, Kosok C,
Abdallah Y, Walther S, Lüdders DW, Neumann T, Tillmanns H, Schäfer
C, Piper HM, et al: Quercetin-induced induction of the NO/cGMP
pathway depends on Ca2+-activated K+
channel-induced hyperpolarization-mediated Ca2+-entry
into cultured human endothelial cells. Planta Med. 71:520–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chou TC: Anti-inflammatory and analgesic
effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J
Pharmacol. 139:1146–1152. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin Z and MacDonald RS: Soy isoflavones
increase latency of spontaneous mammary tumors in mice. J Nutr.
132:3186–3190. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Piret JP, Mottet D, Raes M and Michiels C:
CoCl2, a chemical inducer of hypoxia-inducible factor-1,
and hypoxia reduce apoptotic cell death in hepatoma cell line
HepG2. Ann NY Acad Sci. 973:443–447. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu K, Ning Z, Zhou J, Wang B, Fan J, Zhu
J, Gao Y, Wang X, Hsieh JT and He D: 2′-Hydroxyflavanone inhibits
prostate tumor growth through inactivation of AKT/STAT3 signaling
and induction of cell apoptosis. Oncol Rep. 32:131–138. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singhal SS, Singhal J, Figarola JL, Riggs
A, Horne D and Awasthi S: 2′-Hydroxyflavanone: A promising molecule
for kidney cancer prevention. Biochem Pharmacol. 96:151–158. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsiao YC, Kuo WH, Chen PN, Chang HR, Lin
TH, Yang WE, Hsieh YS and Chu SC: Flavanone and 2′-OH flavanone
inhibit metastasis of lung cancer cells via down-regulation of
proteinases activities and MAPK pathway. Chem Biol Interact.
167:193–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin SY, Kim JH, Lee JH, Lim Y and Lee YH:
2′-Hydroxyflavanone induces apoptosis through Egr-1 involving
expression of Bax, p21, and NAG-1 in colon cancer cells. Mol Nutr
Food Res. 56:761–774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lu KH, Chen PN, Lue KH, Lai MT, Lin MS,
Hsieh YS and Chu SC: 2′-hydroxyflavanone induces apoptosis of human
osteosarcoma 143 B cells by activating the extrinsic TRAIL- and
intrinsic mitochondria-mediated pathways. Nutr Cancer. 66:625–635.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen W, Zhou J, Wu K, Huang J, Ding Y, Yun
EJ, Wang B, Ding C, Hernandez E, Santoyo J, et al: Targeting
XBP1-mediated β-catenin expression associated with bladder cancer
with newly synthetic Oridonin analogues. Oncotarget. 7:56842–56854.
2016.PubMed/NCBI
|
|
23
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu
J, Teng Y, Xia B, Wang R and Zou X: Interaction between
Wnt/beta-catenin pathway and microRNAs regulates
epithelial-mesenchymal transition in gastric cancer (Review). Int J
Oncol. 48:2236–2246. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Faux MC, Coates JL, Kershaw NJ, Layton MJ
and Burgess AW: Independent interactions of phosphorylated
β-catenin with E-cadherin at cell-cell contacts and APC at cell
protrusions. PLoS One. 5:e141272010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Adeniji AO, Chen M and Penning TM: AKR1C3
as a target in castrate resistant prostate cancer. J Steroid
Biochem Mol Biol. 137:136–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ofude M, Mizokami A, Kumaki M, Izumi K,
Konaka H, Kadono Y, Kitagawa Y, Shin M, Zhang J, Keller ET, et al:
Repression of cell proliferation and androgen receptor activity in
prostate cancer cells by 2′-hydroxyflavanone. Anticancer Res.
33:4453–4461. 2013.PubMed/NCBI
|
|
28
|
Gismondi A, Nanni V, Reina G, Orlanducci
S, Terranova ML and Canini A: Nanodiamonds coupled with
5,7-dimethoxycoumarin, a plant bioactive metabolite, interfere with
the mitotic process in B16F10 cells altering the actin
organization. Int J Nanomedicine. 11:557–574. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu MX, Wang M and Yang WW: Gold-quercetin
nanoparticles prevent metabolic endotoxemia-induced kidney injury
by regulating TLR4/NF-kappaB signaling and Nrf2 pathway in high fat
diet fed mice. Int J Nanomedicine. 12:327–345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Tian XJ and Xing J: Signal
transduction pathways of EMT induced by TGF-β, SHH, and WNT and
their crosstalks. J Clin Med. 5:E412016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Angers S and Moon RT: Proximal events in
Wnt signal transduction. Nat Rev Mol Cell Biol. 10:468–477. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Singhal J, Nagaprashantha L, Chikara S,
Awasthi S, Horne D and Singhal SS: 2′-Hydroxyflavanone: A novel
strategy for targeting breast cancer. Oncotarget. 8:75025–75037.
2017. View Article : Google Scholar : PubMed/NCBI
|
